STOCKHOLDERS EQUITY (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Stockholders Equity [Abstract] |
|
| Schedule of ATM Issuances |
| | | | | | | | | | | | | | Average Net Price | | | | | | | Period Ended | Shares issued | | Per Share(1) | | Gross Proceeds | | Net Proceeds | December 31, 2025 | 7,493 | | $ | 36.97 | | $ | 280,887 | | $ | 277,031 | December 31, 2024 | 28,714 | | | 36.49 | | | 1,058,080 | | | 1,047,767 | December 31, 2023 | 7,243 | | | 30.25 | | | 221,732 | | | 219,140 |
| (1) | Represents the average price per share after commissions. |
|
| Schedule of dividend reinvestment and common stock purchase plan |
The table below presents information regarding the shares issued under the DRCSPP for each of the years ended December 31, 2025, 2024, and 2023 (in thousands): | | | | | Period Ended | Shares issued | | Gross Proceeds | December 31, 2025 | 8,783 | | $ | 331,243 | December 31, 2024 | 5,078 | | | 187,969 | December 31, 2023 | 3,715 | | | 117,259 |
|
| Schedule of common stock dividends |
The Board of Directors has declared common stock dividends as set forth below: | | | | | | Record Date | | Payment Date | | Dividend per Common Share | February 10, 2025 | | February 18, 2025 | | $ | 0.67 | May 5, 2025 | | May 15, 2025 | | | 0.67 | August 4, 2025 | | August 15, 2025 | | | 0.67 | November 3, 2025 | | November 17, 2025 | | | 0.67 | February 9, 2026 | | February 17, 2026 | | | 0.67 |
|
| Schedule of per share distribution for income tax purpose |
Per share distributions by our Company were characterized in the following manner for income tax purposes (unaudited): | | | | | | | | | | | | Year Ended December 31, | Common | | 2025 | | 2024 | | 2023 | Ordinary income | | $ | 2.255 | | $ | 1.862 | | $ | 2.258 | Return of capital | | | 0.214 | | | 0.712 | | | 0.212 | Capital gains | | | 0.211 | | | 0.106 | | | 0.210 | Total dividends paid | | $ | 2.680 | | $ | 2.680 | | $ | 2.680 |
|
| Schedule of accumulated other comprehensive income (loss) |
The following is a summary of our accumulated other comprehensive income (loss), net of tax as of December 31, 2025 and 2024: | | | | | | | December 31, | | December 31, | | 2025 | | 2024 | | | (in thousands) | Foreign currency translation | | 20,353 | | | (66,110) | Derivative instruments designated as cash flow hedges(1) | | 66,916 | | | 76,713 | Derivative instruments designated as net investment hedges | | (6,794) | | | 11,898 | Total accumulated other comprehensive income before noncontrolling interest | | 80,475 | | | 22,501 | Add: portion included in noncontrolling interest | | (1,438) | | | 230 | Total accumulated other comprehensive income for Omega | $ | 79,037 | | $ | 22,731 |
(1) | During the years ended December 31, 2025, 2024 and 2023, we reclassified $5.5 million, $9.6 million and $6.7 million, respectively, of net realized gains out of accumulated other comprehensive income into interest expense or other income - net on our Consolidated Statements of Operations associated with our cash flow hedges. |
|